Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taebo Sim

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Cancers|January 8, 2023
Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib ResistanceYunju Nam, Chan Kim, Junghee Han, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2010
1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitorsHana Yu, Yunkyung Jung, Hwan Kim, et al.
Nature Biomedical Engineering|October 22, 2025
Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editingYusang Jung, Goosang Yu, Hyeong-Cheol Oh, et al.
Cancers|June 19, 2024
Correction: Nam et al. Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. <i>Cancers</i> 2023, <i>15</i>, 143Yunju Nam, Chan Kim, Junghee Han, et al.
Journal of Natural Products|September 8, 2012
Structure assignment of lucentamycin E and revision of the olefin geometries of the marine-derived lucentamycinsJin Wook Cha, Jin-Soo Park, Taebo Sim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 29, 2014
Synthesis of quinolinylaminopyrimidines and quinazolinylmethylaminopyrimidines with antiproliferative activity against melanoma cell lineJun A Lee, Eun Joo Roh, Chang-Hyun Oh, et al.
European Journal of Medicinal Chemistry|July 26, 2023
Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitorsNamkyoung Kim, Chan-Jung Park, Younghoon Kim, et al.
Journal of Medicinal Chemistry|November 17, 2015
Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance MutationJohn M Hatcher, Magda Bahcall, Hwan Geun Choi, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2019
Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14Fleur M Ferguson, Zainab M Doctor, Scott B Ficarro, et al.
Frontiers in Immunology|February 19, 2024
A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced goutKihyoun Park, Injae Shin, Yoonseon Kim, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Cancers|January 8, 2023
Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib ResistanceYunju Nam, Chan Kim, Junghee Han, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2010
1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitorsHana Yu, Yunkyung Jung, Hwan Kim, et al.
Nature Biomedical Engineering|October 22, 2025
Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editingYusang Jung, Goosang Yu, Hyeong-Cheol Oh, et al.
Cancers|June 19, 2024
Correction: Nam et al. Identification of Thiazolo[5,4-<i>b</i>]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. <i>Cancers</i> 2023, <i>15</i>, 143Yunju Nam, Chan Kim, Junghee Han, et al.
Journal of Natural Products|September 8, 2012
Structure assignment of lucentamycin E and revision of the olefin geometries of the marine-derived lucentamycinsJin Wook Cha, Jin-Soo Park, Taebo Sim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 29, 2014
Synthesis of quinolinylaminopyrimidines and quinazolinylmethylaminopyrimidines with antiproliferative activity against melanoma cell lineJun A Lee, Eun Joo Roh, Chang-Hyun Oh, et al.
European Journal of Medicinal Chemistry|July 26, 2023
Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitorsNamkyoung Kim, Chan-Jung Park, Younghoon Kim, et al.
Journal of Medicinal Chemistry|November 17, 2015
Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance MutationJohn M Hatcher, Magda Bahcall, Hwan Geun Choi, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2019
Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14Fleur M Ferguson, Zainab M Doctor, Scott B Ficarro, et al.
Frontiers in Immunology|February 19, 2024
A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced goutKihyoun Park, Injae Shin, Yoonseon Kim, et al.
Pageof 13